𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Yawning is elicited by D2dopamine agonists but is blocked by the D1antagonist, SCH 23390

✍ Scribed by G. Serra; M. Collu; G. L. Gessa

Publisher
Springer
Year
1987
Tongue
English
Weight
431 KB
Volume
91
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Attenuation of the locomotor-sensitizing
Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride
✍ Roy A. Wise; William A. Carlezon Jr. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp

Effects of the putative D-1 antagonist S
Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213
✍ Mark T. Pugh; Kathy M. O'Boyle; Anthony G. Molloy; John L. Waddington πŸ“‚ Article πŸ“… 1985 πŸ› Springer 🌐 English βš– 625 KB

The effects of the putative selective dopamine D-1 antagonist benzazepine SCH 23390 and of the selective dopamine D-2 antagonist Ro22-2586 on stereotypy induced by the selective D-2 agonist RU24213 were compared. RU24213 (0.5-15 mg/kg) dose-dependently induced stereo-typed behaviour characterised by